The Federal Bureau of Prison's Efforts to Manage Inmate Health Care

Audit Report 08-08
February 2008
Office of the Inspector General


Appendix VIII
The BOPís Health Care Performance Measures
Description Numerator Denominator Target Percentage
Clinical Management of Hypertension Number of hypertensive patients on medication evaluated this reporting quarter with a blood pressure reading of less <140/< 90 millimeters of mercury Number of patients being treated for hypertension with medication, for a minimum of 6 months, who are evaluated this reporting quarter 2004 - 70%
2005 – 70%
2006 – 70%
2007 – 70%
Clinical Management of Lipid Level Number of patients on lipid reduction medication, with a history of cardiovascular risk or two cardiac risk factors, with a low density lipoprotein level < 100 milligrams reported this reporting quarter Number of patients on lipid reduction medication for a minimum of 6 months, who have lipids measured this reporting quarter and meet requirements listed in the numerator statement 2004 - 65%
2005 – 50%
2006 – 50%
2007 – 65%
Clinical Management of Diabetes – HbA1C Level Number of diabetic patients on insulin or oral medication with an HbA1C level measured 8% or less, as a result of a test this reporting quarter Number of diabetic patients on insulin or oral medication for a minimum of 6 months with HbA1C level measured this reporting quarter 2004 - 65%
2005 – 65%
2006 – 65%
2007 – 65%
Clinical Management of HIV/ Ribonucleic Acid Level Number of inmates on antiretroviral therapy with HIV/ Ribonucleic Acid levels < 50 cps/ml, as confirmed by ultra-sensitive method this reporting quarter Number of inmates on antiretroviral therapy with known HIV/ Ribonucleic Acid standard level of < 400 cps/ml who have had the ultra-sensitive method test this reporting quarter < 50 cps/ml, as confirmed by ultra-sensitive method this reporting quarter 2004 - 60%
2005 – 60%
2006 – 60%
2007 – 85%
Completion of Isoniazid Treatment Number of inmates on treatment for Latent Tuberculosis Infection who have completed bi-weekly isoniazid therapy during this reporting quarter Number of inmates previously started on treatment for Latent Tuberculosis Infection who should have completed treatment within this reporting quarter 2005 – 90%
2006 – 90%
2007 – 90%
Asthma-related Hospitalization or Mortality Number of patients diagnosed with asthma, who are taking chronic asthma medication, and who were not hospitalized, or did not expire from asthma this reporting quarter Number of patients diagnosed with asthma, who are taking chronic asthma medication, and who were in the institution this reporting quarter 2005 – 100%
2006 – 100%
2007 – 98%
Breast Cancer Screening Number of females screened by mammography this reporting period Number of females who require mammography screening this reporting period 2004 - 50%
2005 – 50%
2006 – 50%
2007 – 50%
Cervical Cancer Screening Number of female patients who received screening by PAP this reporting period Number of female patients who would require screening by PAP 2004 - 50%
2005 – 50%
2006 – 50%
2007 – 50%
Pregnancy Testing at Intake Number of new intake females tested for pregnancy this reporting period Number of new female intakes (pre-menopausal) arriving in the institution this reporting period 2004 - 90%
2005 – 90%
2006 – 90%
2007 – 90%



« Previous Table of Contents Next »